The Secretary General for Public Health and R&D&I in Health, Isaac Túnez, has inaugurated the facilities of the Molecular Genetics and Research Unit UGMI of the Torrecárdenas University Hospital in Almería, where the clinical analysis, laboratory, pathological anatomy, haematology, microbiology and immunology units work together and where there are specific spaces for the Biobank as a provincial headquarters linked to the Laboratory and Pathological Anatomy Services.
This new space has allowed the Clinical Analysis, Microbiology and Immunology Sections to grow, adapting their diagnostic capacity to the new healthcare demands and the start-up of the Torrecárdenas Maternity Hospital. In addition, it has allowed a significant provision of space for the Anatomical Pathology service, enabling it to successfully deploy the innovative digital pathology project already underway.
This Unit represents a pioneering and innovative project with the implementation of this multidisciplinary unit of Molecular Genetics and Research that responds to all the healthcare needs of diagnosis, prognosis and treatment of a large number of pathologies that require modern analytical techniques for their clinical management with a high level of quality. To this end, the Laboratories, Haematology and Pathology departments have drawn up a coordinated functional plan to respond to all clinical diagnostic requirements in the areas of oncology, oncohematology, infectious diseases, immune diseases, cardiovascular diseases, genetic diseases, among others. The multidisciplinary approach “will make it possible to share state-of-the-art technologies to provide a high-level service to all the areas of knowledge involved in the unit”, according to the Almeria hospital. To carry out the implementation of this unit, the latest technologies already available in the laboratories of the Hospital Universitario Torrecárdenas (DNA/RNA extraction, in house PCR, RT-PCR or genomic hybridisation techniques) have been installed, but, in addition, new state-of-the-art technologies related to massive gene sequencing and multiarrays have been incorporated.
These new molecular platforms will allow to provide service not only in the care area but also to the research that is already being carried out in the reference centre in the province of Almeria.